WuXi Healthcare Ventures

WuXi Healthcare Ventures

02 Jan 2019
$120,000,000
Venture capital (Series B)

China’s Antengene raises $120m Series B round

AVCJ
+2
18 Sep 2017
28 Jun 2017

Cancer-Focused Vivace Emerges with $40M in Financing Genetic Engineering & Biotechnology News - Biotech from Bench to Business

GEN
+1
18 Aug 2016

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Xconomy
+1
18 Aug 2016
$30,000,000
Venture capital (Series D)

Nutrinia Announces $30 Million Series D Financing to Fund Clinical Development of Lead Product | Business Wire

businesswire
+3
03 Jul 2016
04 May 2016
$46,000,000
Venture capital (Series A)
19 Jan 2016

Same Twist, New Funding: Gene Synthesizer Raises $61M Series D

Xconomy
+1
12 Jan 2016

Syros Pharma raises $40 mln

PE Hub
+1
15 Dec 2015
$30,000,000
Venture capital (Series C)

AltheaDx Raises $30M to Help Doctors Personalize Treatment

Xconomy
+1
03 Jul 2015

23andMe brings in $115M in Series E funding

MedCity News
+1